Description
ESMOZOL-40 Injection is a proton pump inhibitor (PPI) formulated for intravenous administration. It is used for the short-term management of acid-related disorders when oral therapy is not feasible. The lyophilized formulation ensures stability and rapid reconstitution for hospital use.
Mechanism of Action
Esomeprazole selectively inhibits the H⁺/K⁺-ATPase enzyme (proton pump) in gastric parietal cells, thereby:
- Suppressing gastric acid secretion
- Providing prolonged acid control
- Promoting healing of acid-related damage
Indications
- Gastroesophageal Reflux Disease (GERD) (severe cases)
- Erosive esophagitis
- Peptic ulcers (gastric & duodenal)
- Zollinger-Ellison Syndrome
- Prevention of stress-related mucosal damage in critically ill patients
Key Benefits
- Rapid IV action for immediate acid suppression
- Ideal when oral administration is not possible
- Long-lasting acid control
- Supports faster healing of gastrointestinal mucosa
Dosage & Administration
- Administered intravenously (IV) under medical supervision
- Typically 40 mg once daily or as prescribed
- Reconstitute with appropriate diluent before use
Precautions
- For hospital use only
- Monitor patients with liver impairment
- Long-term use may affect vitamin B12 absorption
- Use cautiously in pregnancy and lactation (consult physician)
Storage
- Store below 25°C
- Protect from light and moisture
- Use immediately after reconstitution
